Table 4 The concentration of adalimumab in patients with RA before the fifth, sixth, and seventh administration of 40 mg adalimumab.
No | Before 5th administration | Before 6th administration | Before 7th administration | ||||||
|---|---|---|---|---|---|---|---|---|---|
New method | Conventional method | Accuracy (%) | New method | Conventional method | Accuracy (%) | New method | Conventional method | Accuracy (%) | |
Ada-1 | 523.4 | 512.5 | 102.1 | 582.9 | 606.3 | 96.1 | 540.3 | 527.3 | 102.5 |
Ada-2 | 736.2 | 765.3 | 96.2 | 875.2 | 859.3 | 101.9 | 751.5 | 773.3 | 97.2 |
Ada-3 | 304.5 | 294.2 | 103.5 | 345.5 | 324.5 | 106.5 | 233.1 | 240.4 | 97.0 |
Ada-4 | 164.6 | 186.5 | 88.3 | 126.7 | 134.0 | 94.6 | 186.4 | 207.4 | 89.9 |
Ada-5 | 230.1 | 236.7 | 97.2 | 267.2 | 251.3 | 106.3 | 283.8 | 262.1 | 108.3 |
Ada-6 | 387.1 | 374.5 | 103.4 | 373.3 | 385.1 | 96.9 | 406.9 | 392.4 | 103.7 |
